SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 172 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $28,251 | -68.2% | 47,100 | -31.0% | 0.00% | -100.0% |
Q2 2023 | $88,790 | -35.3% | 68,300 | -12.4% | 0.00% | 0.0% |
Q1 2023 | $137,280 | -44.0% | 78,000 | -0.1% | 0.00% | -50.0% |
Q4 2022 | $245,000 | -55.9% | 78,100 | -31.2% | 0.00% | -60.0% |
Q3 2022 | $556,000 | +26.9% | 113,500 | +7.4% | 0.01% | +25.0% |
Q2 2022 | $438,000 | -28.0% | 105,700 | +1.0% | 0.00% | 0.0% |
Q1 2022 | $608,000 | -23.3% | 104,700 | -0.9% | 0.00% | -20.0% |
Q4 2021 | $793,000 | -31.1% | 105,700 | -17.2% | 0.01% | -37.5% |
Q3 2021 | $1,151,000 | -25.0% | 127,700 | -0.4% | 0.01% | -33.3% |
Q2 2021 | $1,535,000 | -4.4% | 128,200 | 0.0% | 0.01% | -20.0% |
Q1 2021 | $1,606,000 | -21.9% | 128,200 | -2.8% | 0.02% | -25.0% |
Q4 2020 | $2,057,000 | +60.2% | 131,845 | -2.9% | 0.02% | +42.9% |
Q3 2020 | $1,284,000 | -5.1% | 135,845 | -10.1% | 0.01% | -12.5% |
Q2 2020 | $1,353,000 | +17.4% | 151,045 | -16.5% | 0.02% | -5.9% |
Q1 2020 | $1,152,000 | -2.5% | 180,790 | +28.0% | 0.02% | +30.8% |
Q4 2019 | $1,182,000 | -74.2% | 141,275 | -66.7% | 0.01% | -76.4% |
Q3 2019 | $4,575,000 | 0.0% | 424,801 | 0.0% | 0.06% | +1.9% |
Q2 2019 | $4,575,000 | +595.3% | 424,801 | +516.3% | 0.05% | +575.0% |
Q1 2019 | $658,000 | -15.7% | 68,925 | +1.3% | 0.01% | -27.3% |
Q4 2018 | $781,000 | -72.7% | 68,025 | -59.8% | 0.01% | -66.7% |
Q3 2018 | $2,866,000 | +207.5% | 169,110 | +157.8% | 0.03% | +200.0% |
Q2 2018 | $932,000 | -99.9% | 65,600 | +0.2% | 0.01% | -26.7% |
Q1 2018 | $1,244,500,000 | +51.8% | 65,500 | +31.0% | 0.02% | +50.0% |
Q4 2017 | $820,000,000 | +9.3% | 50,000 | 0.0% | 0.01% | 0.0% |
Q3 2017 | $750,000,000 | +70.5% | 50,000 | 0.0% | 0.01% | +66.7% |
Q2 2017 | $440,000,000 | +188.5% | 50,000 | 0.0% | 0.01% | +200.0% |
Q1 2017 | $152,500,000 | +100228.9% | 50,000 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $152,000 | -99.9% | 50,000 | -0.6% | 0.00% | -33.3% |
Q3 2016 | $232,889,000 | -12.2% | 50,300 | +9.8% | 0.00% | -25.0% |
Q2 2016 | $265,182,000 | -4.3% | 45,800 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $277,090,000 | -33.7% | 45,800 | 0.0% | 0.00% | -42.9% |
Q4 2015 | $418,154,000 | +4.9% | 45,800 | -35.2% | 0.01% | 0.0% |
Q3 2015 | $398,748,000 | -55.1% | 70,700 | -11.7% | 0.01% | -50.0% |
Q2 2015 | $887,854,000 | -29.3% | 80,059 | 0.0% | 0.01% | -26.3% |
Q1 2015 | $1,255,325,000 | – | 80,059 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Rokos Capital Management LLP | 6,474,348 | $11,394,852 | 0.84% |
WASATCH ADVISORS LP | 13,642,417 | $24,010,654 | 0.15% |
Avidity Partners Management LP | 2,470,000 | $4,347,200 | 0.14% |
Acrisure Capital Management, LLC | 75,832 | $133,464 | 0.14% |
Golden State Equity Partners | 135,765 | $238,946 | 0.13% |
Long Focus Capital Management, LLC | 1,072,000 | $1,886,720 | 0.11% |
KLK CAPITAL MANAGEMENT LLC | 44,323 | $78,008 | 0.10% |
CAXTON ASSOCIATES LP | 288,218 | $507,264 | 0.08% |
XTX Topco Ltd | 206,334 | $363,148 | 0.08% |
Rhenman & Partners Asset Management AB | 314,157 | $534,067 | 0.06% |